Black-blood MRI

A new MRI technique may identify vulnerable atheromatous plaques likely to rupture.

Written byScience Now
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LONDON, August 11 (SPIS MedWire) Researchers at Mount Sinai Medical School have reported the results of a pilot study involving 'black-blood' MRI — a novel means of noninvasively imaging human coronary arteries. Fayad and colleagues say that the technique, which causes the blood to appear dark while the surrounding tissue and plaques are bright, is the first to accurately image the morphological features of the vessel lumen and wall. The method was tested in 13 subjects, five of whom had coronary artery disease. In the healthy subjects, the average coronary wall thickness, as determined by black-blood MRI (BB-MRI) cross-sectional imaging, was 0.75–0.17mm. In the five CAD patients, BB-MRI identified localized wall thickening ranging from 3.3 to 5.73mm. The differences in maximum wall thickness between the two groups was statistically significant at p<0.001. The authors say the images obtained were high-quality and not affected by cardiac or respiratory motion artefacts, a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform